| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10101344 | The American Journal of Surgery | 2005 | 4 Pages |
Abstract
Cytokeratin IHC provides a clinically relevant adjunct to H&E staining for evaluating sentinel lymph nodes in breast cancer. These data suggest that patients with cytokeratin-positive sentinel nodes are at increased risk for development of regional and distant metastatic disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Philip S. M.D., Tommy A. (F.A.C.S.), Micheal O. M.D., Lydia R. R.N., B.S.N., Elin R. (F.A.C.S.), Marcia C. (F.A.C.S.), John P. (F.A.C.S.), Burton L. (F.A.C.S.), Michael H. (F.A.C.S.),